Business
ANP Submits US Orphan Drug application for ATL1102 in DMD
ANP Submits US Orphan Drug application for ATL1102 in DMD
About this update from Percheron Therapeutics Limited
[{"type":"text","content":"Percheron Therapeutics Limited has released a press release. View Attachment","length":258,"tagName":"div"}]